Nitric oxide: considerations for the treatment of ischemic stroke

  • Terpolilli N
  • Moskowitz M
  • Plesnila N
  • 4


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Some 40 years ago it was recognized by Furchgott and colleagues that the endothelium releases a vasodilator, endothelium-derived relaxing factor (EDRF). Later on, several groups identified EDRF to be a gas, nitric oxide (NO). Since then, NO was identified as one of the most versatile and unique molecules in animal and human biology. Nitric oxide mediates a plethora of physiological functions, for example, maintenance of vascular tone and inflammation. Apart from these physiological functions, NO is also involved in the pathophysiology of various disorders, specifically those in which regulation of blood flow and inflammation has a key role. The aim of the current review is to summarize the role of NO in cerebral ischemia, the most common cause of stroke.

Author-supplied keywords

  • Animals
  • Endothelium, Vascular/metabolism
  • Humans
  • Nitric Oxide/*metabolism
  • Stroke/*metabolism/*physiopathology

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • N A Terpolilli

  • M A Moskowitz

  • N Plesnila

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free